FDA.reportPublic FDA data

selpercatinib 120 MG Oral Tablet

RxCUI
2679805
RxNorm name
selpercatinib 120 MG Oral Tablet
Display name
selpercatinib 120 MG Oral Tablet
Full name
selpercatinib 120 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
7fa848ba-a59c-4144-9f52-64d090f4d828selpercatinib 120 MG Oral TabletSCD22These highlights do not include all the information needed to use RETEVMO safely and effectively. See full prescribing information for RETEVMO. RETEVMO ® (selpercatinib) capsules, for oral use RETEVMO ® (selpercatinib) tablets, for oral use Initial U.S. Approval: 202020251120
7fa848ba-a59c-4144-9f52-64d090f4d828selpercatinib 120 MG Oral TabletSY22These highlights do not include all the information needed to use RETEVMO safely and effectively. See full prescribing information for RETEVMO. RETEVMO ® (selpercatinib) capsules, for oral use RETEVMO ® (selpercatinib) tablets, for oral use Initial U.S. Approval: 202020251120
7fa848ba-a59c-4144-9f52-64d090f4d828selpercatinib 120 MG Oral TabletPSN22These highlights do not include all the information needed to use RETEVMO safely and effectively. See full prescribing information for RETEVMO. RETEVMO ® (selpercatinib) capsules, for oral use RETEVMO ® (selpercatinib) tablets, for oral use Initial U.S. Approval: 202020251120